Cargando…

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer

Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4(th) leading cause of cancer deaths. Sunitinib is a broad-spectrum inhibitor of tyrosine kinase receptors mostly known for its anti-angiogenic effects. We tested the therapeutic effects of sunitinib in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Bosch, Neus, Guerrero, Pedro Enrique, Moreno, Mireia, José, Anabel, Iglesias, Mar, Munné-Collado, Jessica, Anta, Héctor, Gibert, Joan, Orozco, Carlos Alberto, Vinaixa, Judith, Fillat, Cristina, Viñals, Francesc, Navarro, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217016/ https://www.ncbi.nlm.nih.gov/pubmed/27374084 http://dx.doi.org/10.18632/oncotarget.10199

Ejemplares similares

Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
por: Martinez-Bosch, Neus, et al.
Publicado: (2018)

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
por: Martinez-Bosch, Neus, et al.
Publicado: (2018)

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
por: Martínez-Bosch, Neus, et al.
Publicado: (2021)

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib
por: Jiménez-Fonseca, Paula, et al.
Publicado: (2018)

Intraductal Delivery of Adenoviruses Targets Pancreatic Tumors in Transgenic Ela-myc Mice and Orthotopic Xenografts
por: José, Anabel, et al.
Publicado: (2013)

Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
por: Wiedmann, Marcus W., et al.
Publicado: (2012)

Sunitinib Potentiates the Cytotoxic Effect of Electrochemotherapy in Pancreatic Carcinoma Cells
por: Bosnjak, Masa, et al.
Publicado: (2022)

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
por: Fillat, Cristina, et al.
Publicado: (2011)

Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019)

The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer
por: Manero-Rupérez, Noemí, et al.
Publicado: (2020)

Sialyltransferase Inhibitor Ac(5)3F(ax)Neu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice
por: Miró, Laura, et al.
Publicado: (2022)

Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor
por: Valdes-Socin, Hernan, et al.
Publicado: (2017)

The Foundation for Engineering a Pancreatic Islet Niche
por: Patel, Smit N., et al.
Publicado: (2022)

MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer
por: Passadouro, Marta, et al.
Publicado: (2014)

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison
por: Signorovitch, James, et al.
Publicado: (2013)

Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
por: Murase, Yoshiki, et al.
Publicado: (2021)

AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation
por: Maliandi, Maria Victoria, et al.
Publicado: (2015)

What is the relevance of an ambulatory quick diagnosis unit or inpatient admission for the diagnosis of pancreatic cancer? A retrospective study of 1004 patients
por: Bosch, Xavier, et al.
Publicado: (2020)

Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion
por: Guerrero, Pedro Enrique, et al.
Publicado: (2020)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Transformation of Nonfunctioning Pancreatic Neuroendocrine Carcinoma Cells into Insulin Producing Cells after Treatment with Sunitinib
por: Ohn, Jung Hun, et al.
Publicado: (2013)

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
por: Fazio, Nicola, et al.
Publicado: (2021)

Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia
por: Skaraitė, Ieva, et al.
Publicado: (2023)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
por: Tran Cao, Hop S., et al.
Publicado: (2010)

DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
por: Wegner, Catherine S., et al.
Publicado: (2018)

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)
por: Solis-Hernandez, Mª Pilar, et al.
Publicado: (2019)

Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
por: Cáceres, Marta, et al.
Publicado: (2020)

Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche
por: Qadir, Mirza Muhammad Fahd, et al.
Publicado: (2020)

The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention
por: Gumberger, Peter, et al.
Publicado: (2022)

Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
por: Cáceres, Marta, et al.
Publicado: (2021)

Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
por: Sato, Kazuo, et al.
Publicado: (2018)

The Pancreatic Islet Regulome Browser
por: Mularoni, Loris, et al.
Publicado: (2017)

How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis
por: Puig, Ignasi, et al.
Publicado: (2014)

Feedback control of growth, differentiation, and morphogenesis of pancreatic endocrine progenitors in an epithelial plexus niche
por: Bankaitis, Eric D., et al.
Publicado: (2015)

Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
por: Zhao, Jiangang, et al.
Publicado: (2017)

Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche
por: Papalazarou, Vasileios, et al.
Publicado: (2022)

Deciphering microRNA targets in pancreatic cancer using miRComb R package
por: Vila-Casadesús, Maria, et al.
Publicado: (2018)

The protective effects of human milk-derived peptides on the pancreatic islet biology
por: Singh, Amitoj, et al.
Publicado: (2020)

A Synchronous Pancreatic Metastasis from Renal Clear Cell Carcinoma, with Unusual CT Characteristics, Completely Regressed after Therapy with Sunitinib
por: Lauro, Salvatore, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ju5nnb5apeqpkbkk4s02tcdsfg